Megiddo Dalia
SEC insider (Form 3/4/5 filer). CIK 0001599618. Chief Development Officer at Nasus Pharma Ltd (NSRX). 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. Located in TEL-AVIV-YAFO.
Companies Megiddo Dalia has filed insider reports for
- Nasus Pharma Ltd (NSRX): Director, Officer, Chief Development Officer
Megiddo Dalia
CIK: 0001599618
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NSRX
Nasus Pharma Ltd
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions